|
|
|
|
|
|
|
|
re: tumour assay testing
"Conclusions: While the small patient numbers in this trial do not permit definitive conclusions, these data fail to provide support for the argument that prospectively obtained in vitro data regarding platinum or paclitaxel resistance will be highly predictive of clinical outcome in advanced ovarian cancer."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.